ReviewCurrent oncology (Toronto, Ont.)2024

Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma.

Jane E Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.